Discover
VYGR
Voyager Therapeutics, Inc.
3.60
2 x 2.52
2 x 4.46
bid
ask
+
0.10
2.86%
2 @ 04:00 PM
3.51 -0.09 (2.50%)
| Ytd | -8.40% | |
| 1y | 12.50% |
3.44
day range
3.61
2.88
52 week range
5.55
| Open | 3.50 | Prev Close | 3.50 | Low | 3.44 | High | 3.61 | Mkt Cap | 217.52M |
| Vol | 538.66K | Avg Vol | 570.66K | EPS | -1.98 | P/E | N/A | Forward P/E | -3.41 |
| Beta | 0.89 | Short Ratio | 4.44 | Inst. Own | 65.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.74 | 200-d Avg | 4.07 | 1yr Est | 17.10 |
| Income Statement | |||
| Total Revenue | 2.59M | ||
| Revenues (USD) | 2.59M | ||
| Gross Profit | 2.59M | ||
| Operating Expenses | 32.86M | ||
| Research and Development Expense | 24.60M | ||
| Selling, General and Administrative Expense | 8.26M | ||
| Operating Income | -30.27M | ||
| Income Tax Expense | 14.00K | ||
| Net Income | -27.94M | ||
| Net Income Common Stock | -27.94M | ||
| Net Income Common Stock (USD) | -27.94M | ||
| Consolidated Income | -27.94M | ||
| Earnings per Basic Share | -0.47 | ||
| Earnings per Basic Share (USD) | -0.47 | ||
| Earnings per Diluted Share | -0.47 | ||
| Earning Before Interest & Taxes (EBIT) | -27.92M | ||
| Earning Before Interest & Taxes (USD) | -27.92M | ||
| Weighted Average Shares | 59.50M | ||
| Weighted Average Shares Diluted | 59.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 46.05M | ||
| Cash and Equivalents (USD) | 46.05M | ||
| Investments | 128.35M | ||
| Investments Current | 98.17M | ||
| Investments Non-Current | 30.18M | ||
| Trade and Non-Trade Receivables | 1.65M | ||
| Current Assets | 146.98M | ||
| Property, Plant & Equipment Net | 39.43M | ||
| Total Assets | 219.33M | ||
| Debt Current | 7.36M | ||
| Total Debt | 34.57M | ||
| Current Liabilities | 17.45M | ||
| Debt Non-Current | 27.20M | ||
| Total Liabilities | 45.66M | ||
| Accumulated Retained Earnings (Deficit) | -473.84M | ||
| Accumulated Other Comprehensive Income | -263.00K | ||
| Shareholders Equity | 173.67M | ||
| Shareholders Equity (USD) | 173.67M | ||
| Assets Non-Current | 72.34M | ||
| Total Debt (USD) | 34.57M | ||
| Deferred Revenue | 395.00K | ||
| Liabilities Non-Current | 28.20M | ||
| Trade and Non-Trade Payables | 2.72M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.20M | ||
| Net Cash Flow from Financing | 3.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.99M | ||
| Capital Expenditure | -14.00K | ||
| Issuance (Purchase) of Equity Shares | 3.33M | ||
| Net Cash Flow from Investing | 8.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.12M | ||
| Net Cash Flow from Operations | -33.42M | ||
| Share Based Compensation | 2.49M | ||